TP53 and cancer: An increasing body of evidence indicates that mut-p53 promotes the release of soluble mediators (growth factors, cytokines, chemokines), ECM components, remodeling enzymes and exosomes, all of which display autocrine or paracrine activity on tumor and stromal cell populations, hence fostering cancer cell migration and invasion (11–16).